Hydrochlorofluorocarbons (HCFCs) are being developed as replacements for chlorofluorocarbons (CFCs) that deplete stratospheric ozone. The depletion of stratospheric ozone may increase the intensity of ultrviolet radiation at the earth's surface, which may be assodated with global, adverse human health effects. The greater tropospheric lability of HCFCs, which is due to the presence ofC-H bonds, reduces HCFC migration to the stratosphere; HCFCs should, therefore, cause less depletion of stratospheric ozone than CFCs. HCFCs under development include HCFC-22 (chlorodifluoromethane), HCFC-123 (2,2-dichloro-1,1,1-trifluoroethane), HCFC-132b (1,2-dichloro-1,1-difluoroethane), HCFC-134a (1,1,1,2-tetrafluoroethane), HCFC-141b (1,-dich l-fluoroethane, and HCFC-142b (1-chloro-1,1-duoroethane). With the exception ofHCFC-22, which is already in use, the metabolism and toxicity ofHCFCs have not been studied in detail. By analogy to chlorinated ethanes, predictions can be made about the possible metabbolism ofHCFCs, but there are insufficient data available to predict rates of metabolism. Although most HCFCs appear to show low acute toxicity, some HCFCs are mutagenic in the Ames test. Hence, future researh on HCFCs should include studies on the in vivo and in vibo metabolism of HCFCs as well as on their toxicity in in ivo and in vitro systems.
Introduction
Chlorofluorocarbons (CFCs) currently in use are perhalogenated alkanes that find extensive use in four major applications: as refrigerants, as blowing agents in the manufacture of foam plastics, as cleaning fluids, and as propellants. These applications exploit the useful physical properties of CFCs, including low boiling points, specific heats and heats of vaporization, high insulating value, low surface tension and viscosity, and high vapor densities. Moreover, CFCs are nonflammable and relatively free ofadverse health effects; reviews about the toxicity of CFCs have been published (1) (2) (3) .
There is currently much concern about the potential effects of CFCs on stratospheric ozone (4) . Because of their chemical stability, CFCs do not decompose in the troposphere but rise to the stratosphere where ultraviolet radiation catalyzes the release ofchlorine atoms that destroy stratospheric ozone. Stratospheric ozone is an important barrier against ultraviolet radiation and reduces the amount of ultraviolet radiation that may otherwise reach the earth. Depletion of the ozone layer may lead to increased ultraviolet radiation at the earth's surface, and global adverse human health effects associated with increased exposure to ultraviolet radiation, such as an increase in skin cancer and cataract formation, may be seen (5, 6) . These concerns have prompted a search for CFC replacements that are less damaging to the ozone layer. Commercially important CFCs include the perhalomethanes and ethanes fluorotrichloromethane (CFC-ll),* dichlorodifluoromethane (CFC-12), 1,1,2-trichloro-l,2,2-trifluoroethane (CFC-113), 1,2-dichloro-1,1,2,2-tetrafluoroethane (CFC-114), and 2-chloro-1,1,1,2,2-pentafluoroethane (CFC-115). Some CFCs have estimated atmospheric lifetimes in the tens to hundreds ofyears. Bromine-containing fluorocarbons, the so-called halons, have greater ozone-depleting potential than the CFCs, but are used to a lesser extent. A cap on the production ofCFC-ll, 12, 113, 114, and 115 and a production freeze on halon-1211, 1301, and 240'2 was mandated by the Montreal Protocol on Substances that Deplete the Ozone Layer and by Environmental Protection Agency regulations that became effective July 1, 1989 (8,9) ; hence there is a sense of urgency to develop CFC replacements.
Hydrochlorofluorocarbons (HCFCs) have been targeted as replacements for CFCs currently in use because of the greater lability imparted by the presence of C-H bonds, which makes them susceptible to oxidation in the troposphere, and because SThe numeical codes for fluorocarbons have been established by the American Society of Refrigerating Engineers (7) . Briefly, the first digit on the right is the number offluorine atoms in the compound, the second digit from the right is one more than the number of hydrogen atoms in the compound, and the third digit from the right, which is omitted when the digit is zero, is one less than the number ofcarbon atoms in the compound; the number ofchlorine atoms is found by subtracting the sum ofthe fluorine and hydrogen atoms from the total number ofatoms that can be connected to the carbon atoms. In the case ofgeometric isomers, the most symmetrical isomer is indicated by the number alone; as isomers become more unsymmetrical, the letters a, b, c, etc., are appended. Symmetry is determined by summing the atomic weights ofthe substituents attached to each carbon and by subtracting the smaller sum from the larger sum; the smaller the difference the more symmetrical the compound. their physical properties are similar to CFCs. CFC replacements cannot, however, be named with certainty. The toxicological, environmental, and basic thermodynamic properties of most CFC replacements have not been fully investigated, and further investigations may make some potentially useful compounds unsuitable for commercial development. Moreover, cost-effective synthetic methods that can be applied to the commercial-scale production ofHCFCs are not available for all compounds. Information from several sources indicates that the HCFCs listed in Table 1 , and whose chemical structures are shown in Figure 1 , are candidates for development (8) (9) (10) (11) (12) (13) (14) (15) .
The objective of this review is to present current knowledge about the metabolism andtoxicity ofHCFCs, to speculate about the possible metabolic fate ofHCFCs and abouthow metabolism may contribute to toxicity, and to indicate some future research needs.
Metabolism and Toxicity of HCFCs Principles of Metabolism of Halogenated Hydrocarbons
Work conducted over the past two decades has defined the general metabolic pathways of halogenated hydrocarbons and their association with the toxic effects ofhalogenated hydrocarbons. These principles, which should be equally applicable to HCFCs, have been summarized (16, 17 HCFC-22 (50,000 ppm for 5 hr/day for 8 weeks) does not affect male fertility in the rat nor is there evidence of dominant lethality (30) . Exposure of rats to 50,000 ppm HCFC-22 (6 hr/day on days 6 to 15 ofpregnancy) produced a low incidence of microphthalmia and anophthalmia in rats; this effect was not observed in rabbits (28) .
HCFC-22 is mutagenic in the Ames test in Salmonella typhimurium strains TA1535 and TA100 (31); a positive response was obtained in both the absence and presence of S-9 fractions from Aroclor 1254-treated rats. Similar results were obtained in other experiments (28) . HCFC-22 is not mutagenic in Schizosaccharomyces pombe or in Saccharomyces cerevsiae or in a host-mediated assay with S. pombe orS. cerevisiae (32) . Similarly, HCFC-22 was negative in an unscheduled DNA synthesis assay inthe human heteroploid EUE cell line and in V-79 Chinese hamster cells (32) or in a CHO cell line (28, 32) . The ability of HCFC-22 to induce chromosome damage in rat bone marrow cells was studied (28) ; an apparent increase in chromosomal damage was seen at the lowest exposure level but not at two higher exposure levels. Dominant lethal assays ofHCFC-22 in mice have been conducted (28) ; although significant ects were seen, the effects were not systematically related to duration ofexposure or to dose, and the compound produced its effect in the premeiotic phase.
Recent studies report that no treatment-related effects were seen in Sprague-Dawley rats or Swiss mice exposed to by inhalation (1,000 or 5,000 ppm for 4 hr/day, 5 days/week for 104 weeks) (33) . HCFC-22 given by gavage (300 mg/kg, 5 days/week for 52 weeks) did not induce tumors during the 125-week observation period (34, 35 (35) .
Because the pentahaloethanes HCFC-123, 124, and 125 are analogs ofthe anesthetic halothane (2-bromo-2-chloro-l,l,l-trifluoroethane), considerable insight into their possible metabolic fate is available. Recent studies on HCFC-123 and halothane metabolism have been conducted in my laboratory (37) . Studies with 19F nuclear magnetic resonance spectroscopy (19F-NMR) showed that trifluoroacetylated microsomal and cytosolic proteins are present in the livers ofHCFC-123-or halothane-treated rats. The adduct was identified as Ne-trifluoroacetyllysine. Trifluoroacetic acid was identified as the only fluorine-containing metabolite in the urine of HCFC-123-or halothanetreated rats. Immunoblotting studies showed that the pattern of liver proteins immunoreactive with polyclonal, hapten-specific antitrifluoroacetyl protein antibodies was the same in the livers of HCFC-123-and halothane-treated rats. These data indicate that HCFC-123 ( Fig. 2A , X1 = X2 = Cl) andhalothane ( Fig. 2A , XI = Br, X2 = Cl) undergo a cytochrome P450-catalyzed oxygenation to an unstable geminal halohydrin (Fig. 2B , XI = Br or Cl, X2 = Cl), which losesHBror HC to afford trifluoroacetyl chloride (Fig. 2Q . Hydrolysis of acyl halide C gives trifluoroacetic acid (Fig. 2D) , whereas reaction of acyl halide C with nucleophilic sites in proteins yields trifluoroacetylated proteins (Fig. 2E) .
Although the metabolic fate ofHCFC-124 and 125 has notbeen reported, HCFC-124 may yield the geminal halohydrin l-chloro-1,2,2,2-tetrafluoroethanol (Fig. 2B , Xl = Cl, X2 = F) and after hydrolysis, trifluoroacetic acid (Fig. 2D) HCFC-125 may be metabolized to pentafluoroethanol (Fig. 2B , X = X2 = F), which may lose HFtogivetrifluoroacetyl fluoride (Fig. 2D , X2 = F) and, after hydrolysis, trifluoroacetic acid (Fig.  2D) . The oxidative metabolism of halothane is associated with the formation of hepatocyte membrane antigens, which may play a role in halothane hepatitis (38, 39) ; sera from patients and animals exposed to halothane contain antibodies against trifluoroacetylated proteins. Because HCFC-123, 124, and 125 may all be metabolized to trifluoroacetylating agents, it will be important to determine whether there is cross-sensitization between HCFCs and halothane, as has been observed between halothane and enflurane (40) .
Halothane also undergoes cytochrome P-450-catalyzed reductive metabolism to 2-chloro-1,1,1-triflluoroethane (HCFC-133a) and to 2-chloro-1,1-difluoroethene in the presence of lowered oxygen concentrations (20, 21, 41, 42) . This reaction is thought to proceed via a cytochrome P450-catalyzed one-elecctron reduction to an intermediate radical anion, which loses bromine to give the l-chloro-2,2,2-trifluoroethyl radical. Abstraction of a hydrogen atom from polyunsaturated lipids would yield the observed metabolite 2-chloro-1,1,1-trifluoroethane, whereas the homolytic elimination of fluorine would afford the alkene 2-chloro-1,1-difluoroethene, also a known metabolite of halothane. By analogy with the metabolism of halothane, the reductive metabolism of HCFC-123 may yield 2-chloro-1,1,1-trifluoroethane and 2-chloro-I,j-difluoroethene (Fig. 2) ; the reductive metabolism of HCFC-124 and 125 may yield 1,1,1,2-tetrafluoroethane (HFCF-134a) and trifluoroethene (Fig. 2) . Whereas it is possible to make qualitative predictions about the metabolic fate of HCFC-123, 124, and 125, there is insufficient information available to predict their rates of metabolism, although metabolism usually decreases with increasing fluorination.
HCFC-132b. The lowest observed lethal concentration of HCFC-132b is 20,000 ppm/4 hr in the rat (43) . HCFC-132b undergoes dechlorination (1.2%) when incubated with rat hepatic microsomes (44) . Rats exposed by inhalation to HCFC132b (500,2,000, or 5,000 ppm for 6 hr/day, 5 days/week for 13 weeks) showed proliferation of bile duct epithelial cells, testicular damage, elevated liver-, heart-, kidney-, and lung-tobody weight ratios, decreased brain and testes weights, and low activity and responsiveness to noise (45) . HCFC-132b undergoes extensive metabolism in the rat (46) . The major metabolite was identified as 2-chloro-2,2-difluoroethyl glucuronide. Chlorodifluoroacetic acid was present in the urine of HCFC-132b-treated rats along with chlorodifluoroacetaldehyde (Fig. 3A , X = Cl) may undergo oxygenation to yield 1,2-dichloro-2,2-difluoroethanol (Fig. 3B , X = Cl), which may lose HCI to give chlorodifluoroacetaldehyde (Fig. 3C, X (46) . These results are consistent with the generalization that protein acylation may be associated with the metabolism of geminal dihaloethanes to acyl halides; HCFC-132b should not be metabolized to an acyl halide and would not, therefore, be expected to acylate proteins. The toxicity of2-chloro-2,2-difluoroethanol has not been investigated, but the fluorinated analog 2,2,2-trifluoroethanol is toxic (47) .
The cytochrome P-450-dependent reductive metabolism of 1,1,1,2-tetrachloroethane yields l,1-dichloroethene as the major metabolite (23) and 1,1,2-trichloroethane as a minor metabolite (22, 48) . These results are consistent with the generalization that chloroethanes with vicinal chlorine substituents may be reductively metabolized to haloalkenes by didechlorination (48) . If these generalizations apply to HCFCs, HCFC-132b may be metabolized to 1,1-difluoroethene and 2-chloro-1,l-difluoroethane (Fig. 3) . 1,l-Difluoroethene induces the formation of preneoplastic foci in rats, although the compound is much less potent than chloroethene (49) . HCFC-134a. has been tested as an inhalational anesthetic agent and reported to have no direct toxic effects (50) . HCFC-134a is not mutagenic in the Ames test (35) . The cytotoxicity of HCFC-134a has been studied in isolated rat hepatocytes (51) . Head-space HCFC-134a concentrations 575% did not increase lactate dehydrogenase release from hepatocytes. In hepatocytes isolated from fed rats, HCFC-134a (e 12.5%) increased glycolysis and the lactate/pyruvate ratio and decreased glucose production; in hepatocytes from fasted rats, HCFC-134a inhibited gluconeogenesis. Recent studies on the metabolism of HFCF-134a have been reported (52, 53) . HCFC-134a undergoes metabolism, as measured by the release of inorganic fluoride, in isolated rat hepatocytes (52) and in rat hepaticmicrosomes (53) . HCFC-134a defluorination in hepatocytes is proportional to the head-space HCFC-134a concentration; with 50% HCFC-134a, fluoride release amounted to 12 nmole F-/mg protein/ 2 hr. HCFC-134a defluorination is decreased in heat-treated hepatocytes, is inhibited by pyrazole and halothane, and is increased in hepatocytes isolated from phenobarbital-treated rats. In hepatic microsomes, HCFC-134a defluorination is also proportional to the head-space HCFC-134a concentration; with 50% HCFC-134a, fluoride release amounted to 6nmole F-/mg protein/15 min. The microsomal metabolism of HCFC-134a is inhibited by carbon monoxide, is decreased in the presence of low oxygen concentrations, and is increased in microsomes isolated from Aroclor-treated rats. These results indicate that HCFC-134a undergoes a cytochrome P-450-catalyzed defluorination reaction, and recent studies implicate cytochrome P450 isoformIIEI in the reaction (54). Although reaction mechanism studies have not yet been reported, the cytochrome P-450-dependent oxidative metabolism of HCFC-134a may yield 1,2,2,2-tetrafluoroethanol, which may lose HF to give trifluoroacetaldehyde; fluoride is a known metabolite ofHCFC-134a (52, 53) . Trifluoroacetaldehyde may be reduced to 2,2,2-trifluorethanol or oxidized to trifluoroacetic acid (Fig. 3) . The reductive metabolism ofHCFC-134a may yield 1,1-difluoroethene and 1,1,2-trifluoroethane as metabolites (Fig.  3) . The possible formation of 2,2,2-trifluoroethane as a metabolite of HCFC-134a is of particular interest in view of the observed gastrointestinal toxicity and hematotoxicity of 2,2,2-trifluoroethanol (47) .
HCFC-141b. The mammalian toxicity of HCFC-141b has not been studied. HCFC-141b undergoes dechlorination (1.0%) when incubated with rat hepatic microsomes (44) . The chlorinated analog 1,l,1-trichloroethane is metabolized to 2,2,2-trichloroethanol, which may be excreted as its glucuronide conjugate, and to trichloroacetic acid in rats and humans (55, 56) . With rat hepatic microsomal and nuclear fractions as the enzyme sources, 1,l,l-trichloroethane is metabolized to 2,2,2-trichloroethanol (57, 58) . Based on these precedents, expected metabolites of HCFC-141b include 2,2-dichloro-2-fluoroethanol, which may be further oxidized to dichlorofluoroacetaldehyde and dichlorofluoroacetic acid (Fig. 4) . Preliminary studies with '9F-NMR in rats exposed by inhalation to HCFC-141b showed the presence of a single fluorine-containing metabolite in urine in low concentrations, which has tentatively been identified as 2,2-dichloro-2-fluoroethyl glucuronide (59) . The toxicity of 2,2-dichloro-2-fluoroethanol has not been reported, but, as noted, above, the analog 2,2,2-trifluoroethanol is toxic (47) .
HCFC-142b. The lowest observed lethal concentration of HCFC-142b in the rat is 50 pph/30 min (60) . HCFC-142b undergoes dechlorination (0.6%) when incubated with rat hepatic microsomes (44) . is mutagenic in the Ames test with S. typhimurium TA1535 or TA100 as the test organisms (35) and in a BHK21 cell-transformation assay (34, 35) . Rats exposed to HCFC-142b by inhalation (100, 10,000, or 20,000 ppm for 6 hr/day, 5 days/week for 13 or 15 weeks) did not show compound-related effects in a bone marrow cytogenetic assay or in a dominant lethal assay (61) . No treatment-related effects were observed in a 90-day study of rats and dogs exposed by inhalation to HCFC-142b (1,000 or 10,000 ppm for 6 hr/day, 5 days/week for 90 days) (62) or in a 104-week study ofrats exposed by inhalation to HCFC-142b (1,000, 10,000, or 20,000 ppm for 6 hr/day, 5 days/week for 104 weeks) (61) .
Apart from the observation that HCFC-142b undergoes dechlorination (44) , the metabolism of HCFC-142b has not been investigated. 
